Background--Only a few studies have systematically evaluated fluoroscopy data of electrophysiological and device implantation procedures. Aims of this study were to quantify ionizing radiation exposure for electrophysiological/device implantation procedures in a large series of patients and to analyze the x-ray exposure trend over years and radiation exposure in patients undergoing atrial fibrillation ablation considering different technical aspects.
O ver the past 20 years, the growing number of electrophysiological (EP) procedures and device implantations (DIs) has caused increased concern over potential radiation risk effects. 1 Fluoroscopy imaging involves a nonnegligible exposure to ionizing radiation for both patients and electrophysiology laboratory personnel, depending on laboratory workload and the complexity of the procedures. 2 Effects of exposure to ionizing radiation include deterministic and stochastic effects. The latter is particularly relevant in young patients, as a consequence of their higher radiosensitivity and longer life span, and in patients undergoing long, complex, or repeated procedures because of cumulative high radiation doses. [3] [4] [5] [6] [7] [8] On the other hand, the total exposure also may lead to a significant cumulative dose and lifelong radiation risk to the electrophysiology staff. 9, 10 For this reason, the European Directives and the International Commission on Radiological Protection recommend that physicians should be guided by the diagnostic reference levels for an appropriate use of radiation. 11 Recently, the major cardiovascular societies have published recommendations about x-rays use in interventional cardiology and suggested practical ways to reduce them. [12] [13] [14] This can be achieved by raising operator awareness, optimizing the technical settings of the x-ray system, or using a 3-dimensional electroanatomic mapping (EAM) system. However, to date, there are few data evaluating in a systematic way fluoroscopy time, dose exposure in terms of dose area product (DAP), radiation-related risk evaluated by effective dose (ED) and lifetime attributable risk of cancer incidence in patients undergoing EP/DI procedures. Furthermore, diagnostic reference levels for EP/DI procedures have not yet been proposed.
The aims of this study are: (1) to quantify ionizing radiation exposure for all types of EP/DI procedures in a large series of patients; (2) to analyze the x-ray exposure trend over the years, considering that no institutional changes and/or recommendations about fluoroscopy use were performed and operators are free to use fluoroscopy according to their sensitivity; and (3) to analyze radiation exposure in patients undergoing atrial fibrillation (AF) ablation considering the ablation technique, redo procedures, preprocedural computed tomographic (CT) scan and the experience of operators.
Finally, based on our results, we propose and promote the use of updated diagnostic reference levels for EP/DI procedures, as they are an important reference for every electrophysiology laboratory to compare itself with the present standard.
Methods
This is a retrospective study conducted at the Heart Rhythm Center at Centro Cardiologico Monzino IRCCS, Milan, Italy. The Institutional Review Board approved the study. All patients gave a generic written consent for scientific purposes. The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. The data that support the findings of this study are available from the corresponding author on request.
The electrophysiology database of our institution was reviewed to identify all patients who underwent EP and DI procedures between January 2010 and December 2016.
Electrophysiological procedures included EP studies, catheter ablation of supraventricular tachycardia, atrial flutter and atrial tachycardia, AF, premature ventricular contractions, ventricular tachycardia.
DI included implantation of a permanent pacemaker or cardioverter-defibrillator and cardiac resynchronization therapy devices.
Demographic, clinical, and procedural data were collected, including age, sex, type of electrophysiological procedure, fluoroscopy time, and DAP incurred to the patient. In the case of atrial fibrillation ablation patients, we also took into account history of previous AF ablation procedures, ablation technology used, preprocedural CT scan, and first operator's experience. Only cases with availability of all clinical, procedural, and fluoroscopic data were included in the study.
All procedures were performed by 12 operators routinely working at the Center; of these, 7 operators performing at least 50 AF procedures per year in the past 10 years were considered experienced AF ablation operators. 11 Because our institution has a cardiology fellowship training program, all procedures entailed some degree of fellow education involving catheter manipulation. During this 7-year period, no institutional changes or recommendations about fluoroscopy use were made, but operators, according to their sensitivity and x-ray awareness, have adapted their method of working.
The procedures were performed in 3 different electrophysiology rooms; in all 3 rooms, x-ray imaging was performed using a GE Innova 2100IQ (General Electric Healthcare) with total filtration of 3 mCu, and anodic angle of 120°. The screening fluoroscopy was routinely performed at the factory low setting of 7.5 pulses per second, pulse length of 6 ms, field of view of 20 cm, energy per frame of 70 to 80 kV, no collimation, and with the secondary radiation grid in situ.
Clinical Perspective
What Is New?
• Comprehensive fluoroscopy data (fluoroscopy time, dose-area product, effective dose) for electrophysiological procedures are reported in a large "real-life" electrophysiological population.
• An assumption for the lifetime attributable risk was assessed.
• The analysis of the x-ray use in 7 experienced operators performing AF ablation showed an overall significant difference in fluoroscopy use among them.
What Are the Clinical Implications?
• Awareness and culture of radiation-related risk and technological advances can successfully optimize fluoroscopy use.
Because of the necessity of image storing, we stored the last fluoroscopy image in most cases, while we used angiography only in selected cases (ie, cryoablation, cardiac resynchronization therapy, and epicardial ventricular tachycardia ablation For supraventricular tachycardia, a 3-dimensional electroanatomic mapping system was used only in selected cases in order to obtain a minimal fluoroscopic approach. All other procedures were performed with fluoroscopy only.
Statistical Analysis
All outcome measures were skewed by continuous variables; therefore, nonparametric tools were used. Standard descriptive statistics were used to summarize the data and expressed as median (with range or interquartile range).
Differences in measures of radiation exposure across procedural and interventional types were tested using the Kruskal-Wallis test (nonparametric analog of ANOVA), and then further compared after adjustment using linear regression.
Correlations between variables were determined using P trends of variation from 2010 to 2016 were assessed by the analysis of covariance (ANCOVA).
All statistical analyses were performed using SPSS v.22 and SAS 9.4. Statistical significance was established a priori at a 2-tailed P<0.05.
Results
Between January 1, 2010, and December 31, 2016, a total of 7795 EP procedures and 2805 DIs were performed in our center. All clinical, procedural, and fluoroscopic data were available on 8150 procedures that constituted the study population.
Overall study population consisted of 2416 AF ablations (mean age 60AE11; 74% male); 468 atrial flutter or atrial tachycardia ablations (mean age 60AE16; 74% male); 979 supraventricular tachycardia ablations (mean age 45AE18; 44% male; 113 procedures were performed according to a minimal fluoroscopic approach); 453 ventricular tachycardia ablations (mean age 61AE16; 89% male); 450 premature ventricular contraction ablations (mean age 47AE17; 64% male); 1329 EP studies (mean age 54AE19; 69% male); 1743 permanent pacemaker/cardioverter-defibrillator implantations (mean age 74AE12; 67% male); and 312 cardiac resynchronization procedures (mean age 70AE10; 76% male). Table 1 summarizes study population distribution over the 7-year study period.
Fluoroscopy exposure data for the study population are summarized in Table 2 . In the same table, the estimated lifetime attributable cancer risk is calculated. For example, in our population, a patient who underwent an AF ablation had a potential increased cancer risk of 0.16% over the base rate risk; that means that there is potentially an excess of 160 cancers observed in a population of 100 000 treated patients.
Overall, our fluoroscopy data results were comparable to fluoroscopy exposure reported in the literature. In Table S1 , we report a brief nonsystematic review of available data regarding fluoroscopy use and dose, considering only studies with at least 50 patients and that reported either DAP or ED.
Fluoroscopy Exposure Data Over Time
Fluoroscopy use and radiation exposure data for different EP/DI procedures were analyzed over time (Table 3) . A fluoroscopy exposure trend was calculated showing a significant reduction (P<0.0001) in fluoroscopy time and DAP and ED values for AF, atrial flutter/atrial tachycardia, supraventricular tachycardia, ventricular tachycardia, premature ventricular contraction ablation, and electrophysiological studies (ED-electrophysiological studies: P = 0.02), while a not significant consensual reduction in all exposure values was observed for both permanent pacemaker/cardioverterdefibrillator and cardiac resynchronization device implantation procedures.
Fluoroscopy Exposure in AF Ablation Procedure

Analysis according to operators
Seven different experienced electrophysiology operators (>50 procedures per year in the past 10 years) were compared in order to evaluate the differences in the use of x-rays over the course of 7 years. Overall, there was a significant variability (P<0.0001) of fluoroscopy time, DAP, and ED values among operators (Table 4) .
Interestingly, over 7 years of activity, all the operators significantly decreased (P<0.0001) the use of x-rays with Continued fluoroscopy time delta values ranging from À44% to À69% and DAP delta values ranging from À53% to À77% (Figure 1 and Table 5 ). A strong linear relationship (r=+0.71883, P<0.0001) between fluoroscopy time and radiation dose over time was observed. Statistically different correlation coefficients were observed among operators (P<0.001), likely representing different x-ray system technical settings and utilization among operators. Table 5 shows x-ray use performance over time of the 7 experienced electrophysiological operators.
Analysis according to AF ablation technique
We compared fluoroscopy exposure data with 2 different AF ablation techniques: manual radiofrequency catheter ablations guided by electroanatomic mapping systems and cryoablation procedures. The rate of manual radiofrequency catheter ablations guided by electroanatomic mapping systems and cryoablation procedures significantly varied over time (P<0.01) as cryoablation procedures progressively increased from 13% of AF ablations in 2010 up to 27% in 2016.
Overall, 1809 (75%) manual radiofrequency catheter ablations guided by electroanatomic mapping systems were performed, counting for a median fluoroscopy time of 24 (15- 
Redo AF ablation procedures
We evaluated the rate of AF ablation redo procedures, and we observed that 21% of patients had previously undergone ≥1 AF ablations, with an average of 1.25 procedures and a maximum of 5 procedures per patient. In patients that underwent >1 AF ablation, the radiation dose of each procedure cumulates, and the overall radiation-related risk should be considered before performing a redo procedure. 
Discussion
Radiofrequency catheter ablation is often the first-line therapy for several types of cardiac arrhythmias, and fluoroscopic guidance during catheter ablation remains the cornerstone in electrophysiology laboratories. Therefore, EP/DI procedures are associated with a nonnegligible radiation risk for both patients and operators. For this reason, in recent years the "ALARA" principle for cardiac interventions has been highlighted, which means using techniques and procedures to keep x-ray exposure to a level As Low As Reasonably Achievable. Accordingly, the major cardiovascular associations have published detailed recommendations about x-ray use and suggested practical ways to reduce it. 1,12-14 Nevertheless, the majority of published studies report only fluoroscopy time (ie, an indirect measure that cannot be adequately correlated to the risk associated with x-ray exposure) and, to date, there are only a few and/or small studies reporting in detail DAP and ED. To our knowledge, our study is the first published study performed in a large population reporting comprehensive data on fluoroscopy exposure and therefore giving an estimate of the effective risk correlated to the use of x-rays in EP and DI procedures.
Recently, Voskoboinik and colleagues 17 described a reduction in radiation dose in AF ablation over time in a large series of patients. The authors related this result to operator experience, annual case volume, technology evolution, and recent contact force-sensing catheter technology. In our experience, evaluating the trend of fluoroscopy data over 7 years, the use of x-rays was significantly reduced in most EP/DI procedures. As highlighted in previous studies, technology improvement could explain significant x-ray reduction time during more complex procedures. [18] [19] [20] [21] We observed a significant trend in lowering use of x-ray in all types of procedures; this may not be attributed only to technology improvement.
In the workflow adaptations in order to reduce radiation exposure proposed by the European Heart Rhythm Association's Practical Guide, 1 the first recommendation regards electrophysiologists' and catheter laboratory personnel's constant awareness. This point is clearly evident in our data. Considering the analysis of x-ray use by 7 experienced operators performing AF ablation, we observed an overall significant difference in fluoroscopy use among them. The analysis of correlation between fluoroscopy time and DAP reduction over time revealed that reduction in fluoroscopy use led to a different DAP reduction among operators. These data can be attributed to several factors such as appropriate use of fluoroscopy, the operator's preference for extreme angulated left anterior oblique in contrast with "reduced" left anterior oblique or anteroposterior projection, the operator's preference for one ablation technology or another, and so on. However, over 7 years, all of the operators reduced their amount of both fluoroscopy time and DAP, showing that the use of fluoroscopy is not strictly a function of experience and that the awareness of the harm correlated with x-rays and the presence of a background in radiation safety are the cornerstones for reducing radiation exposure in interventional cardiology. 22, 23 Looking at fluoroscopy time, DAP, and ED in different procedures and for different operators, we should note that fluoroscopy time is only an indirect and incomplete measure of the radiological exposure. In fact, fluoroscopy time reduction did not always correspond to a consensual statistically significant reduction of DAP; DAP value depends on patients' body structure (eg, thoracic impedence) and appropriate use of fluoroscopy (eg, detector position, projection angle, collimation, magnification, frame-rate). Of note, the individual radiological risk is a function of patients' age and sex. Therefore, the report of fluoroscopy time should not be considered enough per se and the report of DAP and/or ED should be encouraged in all centers and studies. Furthermore, the individual lifetime excess risk of cancer incidence and mortality is estimated only thanks to the value of procedural ED.
Considering AF ablation techniques, previous papers 24 demonstrated that fluoroscopy time was longer in cryoablation than radiofrequency ablation; moreover, data of dose exposure associated with cyoablation are not available.
In our long-term experience, cryoablation gradually reduced the procedural fluoroscopy time until it was comparable to radiofrequency catheter ablation. A similar trend may also be observed for dose exposure, although, over 7 years, cryoablation is still associated with higher values of DAP and ED compared to radiofrequency catheter ablation. When performing an electrophysiological procedure, operators should always consider that it might not be the only one performed with the use of x-rays. In fact, patients may be expected to undergo ≥1 ablation procedure in their lifetime (average AF ablation procedures: 1.5 in literature, 25 1.25 in our series), and they are often subject to other diagnostic x-ray examinations (ie, cardiac CT scan, coronary angiography, percutaneous angioplasty). In our population, a patient undergoing a rhythm control strategy with a catheter ablation varies his radiological exposure from a minimum of 3.6 mSv (one catheter ablation procedure, no preprocedural CT scan, minimum interquartile range ED value overtime) up to 100 mSv (>1 procedure, preprocedural CT scan, maximum interquartile range ED value). This results in a nonnegligible estimated excess risk of cancer malignancy induction ranging from 36 in 100 000 treated patients up to 1 in 100. Therefore, x-ray awareness and culture is particularly important in all procedures for all operators as well as patients. Finally, we observed that our fluoroscopic exposure data were consistent with data from the European recommendations. 14 We acknowledge that there are some studies showing significantly lower x-ray exposure even in complex procedures. However, these data were obtained by designed trials with selected experienced operators and often by studies aiming at demonstrating radiation reduction exposure with different techniques. On the contrary, our data derive from the "real life" of a training center without any selection of operators and procedures and where the learning curve of electrophysiology fellows and the learning curve for the numerous continuously evolving technologies introduced should be taken into account. We acknowledge that our single-center data cannot be a reference, but we suggest that consensus groups start working on radiation exposure at a society level with the aim of proposing updated diagnostic reference levels for electrophysiological procedures. In Table 6 , we propose the values of fluoroscopy time and DAP diagnostic reference levels according to our population.
Study Limitations
Our study was a retrospective analysis of procedures performed in the past 7 years; unfortunately, we had incomplete fluoroscopic data for some procedures. Moreover, we did not report patients' body mass index, and the estimation of ED was performed with the simplified formula suggested by the European Heart Rhythm Association's Practical Guide. 1 We should also acknowledge that we included data from operators with significantly different experience and from many procedures that also involved trainees. However, we think that it could be considered a positive feature of our study because it gives a picture of the real electrophysiological life.
Conclusions
Electrophysiological procedures involve a nonnegligible use of x-rays. Awareness of the associated risks is fundamental, and together with technological improvement, it can successfully reduce and optimize the use of fluoroscopy. Diagnostic reference levels are important for every electrophysiology laboratory to compare itself with the present standard. Currently, fluoroscopic reference values are derived from the procedures performed in previous decades. In the past few years, several papers have shown that growing operator x-ray awareness and rapid technological advances have led to a progressive reduction in fluoroscopy use in the electrophysiology laboratories. In this context, we suggest that consensus groups start working at a society level with the aim of proposing updated diagnostic reference levels. 
